AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
136
Employees136
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
136
Employees136

ANAB Key Statistics

Market cap
1.23B
Market cap1.23B
Price-Earnings ratio
-15.73
Price-Earnings ratio-15.73
Dividend yield
Dividend yield
Average volume
621.81K
Average volume621.81K
High today
$44.84
High today$44.84
Low today
$41.50
Low today$41.50
Open price
$43.53
Open price$43.53
Volume
351.38K
Volume351.38K
52 Week high
$45.32
52 Week high$45.32
52 Week low
$12.21
52 Week low$12.21

Stock Snapshot

The current AnaptysBio(ANAB) stock price is $44.35, with a market capitalization of 1.23B. The stock trades at a price-to-earnings (P/E) ratio of -15.73.

On 2025-12-07, AnaptysBio(ANAB) stock moved within a range of $41.50 to $44.84. With shares now at $44.35, the stock is trading +6.9% above its intraday low and -1.1% below the session's peak.

Trading volume for AnaptysBio(ANAB) stock has reached 351.38K, versus its average volume of 621.81K.

Over the past 52 weeks, AnaptysBio(ANAB) stock has traded between a high of $45.32 and a low of $12.21.

Over the past 52 weeks, AnaptysBio(ANAB) stock has traded between a high of $45.32 and a low of $12.21.

ANAB News

Simply Wall St 2d
AnaptysBio: Assessing Valuation After Legal Battle Over Jemperli Royalties and Future Cash Flows Escalates

AnaptysBio (ANAB) just turned its long running Jemperli partnership with Tesaro and GSK into a full blown legal battle, and that tug of war over royalties and r...

AnaptysBio: Assessing Valuation After Legal Battle Over Jemperli Royalties and Future Cash Flows Escalates

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.